[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 4 sources · 12 days · First seen · Last updated

Development of intelligent transdermal medical patches

Overview

Researchers are advancing the development of intelligent transdermal patches for targeted medical treatments. One approach, the NextSkins project funded by the European Union, involves using engineered living materials to create patches for atopic dermatitis. These patches utilize modified microorganisms, such as yeast, to detect bacterial enzymes and release therapeutic molecules directly to the affected area.

Parallel developments include the creation of intelligent wound dressings designed to treat chronic conditions like diabetic foot syndrome. These materials utilize light to control the release of active ingredients. Such transdermal therapeutic systems offer a non-invasive alternative to oral medications, providing continuous drug delivery while reducing systemic side effects and improving patient adherence.

Entities

European Union · Imperial College London · NextSkins · Empa · Tom Ellis

Timeline

  1. [HEALTH] 2 sources
    Empa researchers develop light-controlled patches for wound treatment

    New developments in transdermal technology include light-controlled wound dressings from Empa and patches that provide continuous drug delivery to bypass the gastrointestinal tract.

  2. [HEALTH] 2 sources
    Researchers develop living patches to treat atopic dermatitis

    Researchers under the EU-funded NextSkins project are developing “living patches” using engineered yeast to provide targeted treatment for eczema flare-ups.

Sources

ad-hoc-news.de · devicemed.de · forssanlehti.fi · hameensanomat.fi